New study on 2018 Zika Virus Vaccines added to Wise Guy Reports Database, propose that the virus vaccines developed by pharmaceutical companies supported by research institutes and World Health Organization (WHO) are becoming more popular.
With fears of Zika virus reaching new heights, Zika virus vaccines are gaining popularity. Many Government agencies and research institutes support pharmaceutical companies for the development & manufacturing of Zika virus vaccines. It is predicted that Zika virus vaccines shot will available to the public by 2018.
The research presents comprehensive study of the Zika virus vaccines. It gives essential insights of introduction of Zika virus, current situation and areas with Zika virus and funding in Zika virus vaccines research.
Also, the report includes assessment of clinical trials and regulatory landscape of Zika virus vaccines development. Key trends in terms of partnerships, collaborations and licensing agreements are analyzed with details.
The report concludes with the profiles of major players in the Zika virus vaccines development such as Sanofi Pasteur, ImmunoVaccines Inc, Inovio Pharmaceuticals, Inc, Valneva, Bharat Biotech International Pvt. Ltd., NewLink Genetics.
The major players are evaluated on various parameters such as company overview, product outlook and Zika virus vaccines latest development and trends.
Zika virus is an emerging viral disease that is transmitted through the bite of an infected mosquito, primarily Aedes aegypti, the same vector that transmits chikungunya, dengue and yellow fever. Zika has a similar epidemiology, clinical presentation and transmission cycle in urban environments as chikungunya and dengue, although it generally causes milder illness.
